Update on Korea China Japan Tripartite Clinical Trial ... - Apec-ahc.org

More documents

Recommendations

Info

Numbers of All CTN Trends of MRCTs Including Japan (1/2) - % of MRCTs in Clinical Trial Notifications - 300 250 200 150 100 50 0 Early FY2007 (Apr-Sep) : Total number of Clinical Trial Notification (CTN) : Number of MRCT CTN Late Early Late Early FY2007 FY2008 FY2008 FY2009 (Oct-Mar) (Apr-Sep) (Oct-Mar) (Apr-Sep) Late FY2009 (Oct-Mar) Early FY2010 (Apr-Jul) 25 20 15 10 5 0 % of MRCTs
Trends of MRCTs including Japan (2/2) - Operational Regions of MRCTs in FY2009 - Japan+US/EU Unknown 15.0% 16.8% FY2009 12.4% 55.8% East-Asia Only World-Wide 3
Page 1: Update on Korea Ch
Page 5 and 6: ILD on Temsirolimus Clinical Trial
Page 7 and 8: Japan’s Activities on Ethnic Fact
Page 9 and 10: Summary of PK data analysis Ethnic
Page 11 and 12: Relative AUC difference Moxifloxaci
Page 13 and 14: APEC LSIF (Life Science Innovation
Page 15 and 16: 1. Overall Recommendations A) MRCTW
Page 17 and 18: Asia’s Role in Global Drug Develo
Page 19 and 20: 国際共同試験での日本人
Page 21 and 22: Ethnic Difference in Pharmacokineti
Page 23: Difference among East Asian populat

Update on Korea China Japan Tripartite Clinical Trial ... - Apec-ahc.org

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?